Who are Bicarbonate de sodium's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): NaHCO3, sodium bicarbonate 4.2%, Bicarbonate endovenous hydratation, Lower Dose Sodium Bicarbonate.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/bicarbonate-de-sodium.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Bicarbonate de sodium — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bicarbonate de sodium (Bicarbonate de sodium) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Alkalizing agent. Area: Critical Care / Metabolic Disorders.

marketed Alkalizing agent Critical Care / Metabolic Disorders Small molecule Live · refreshed every 30 min

Target snapshot

Bicarbonate de sodium (Bicarbonate de sodium) — Nantes University Hospital. Sodium bicarbonate acts as a systemic alkalizing agent that increases blood pH and bicarbonate levels to counteract acidosis.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Bicarbonate de sodium TARGET	Bicarbonate de sodium	Nantes University Hospital	marketed	Alkalizing agent
NaHCO3	NaHCO3	Karadeniz Technical University	marketed	Antacid / Alkalizing agent
sodium bicarbonate 4.2%	sodium bicarbonate 4.2%	Sheba Medical Center	marketed	Alkalizing agent
Bicarbonate endovenous hydratation	Bicarbonate endovenous hydratation	David Garcia Cinca	phase 3	Electrolyte/alkalizing agent
Lower Dose Sodium Bicarbonate	Lower Dose Sodium Bicarbonate	Jennifer Gassman, PhD	phase 3	Alkalizing agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Alkalizing agent class)

Jennifer Gassman, PhD · 1 drug in this class
Nantes University Hospital · 1 drug in this class
Sheba Medical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Bicarbonate de sodium — Competitive Intelligence Brief. https://druglandscape.com/ci/bicarbonate-de-sodium. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing